Muviri wemuviri
0102030405
01
ADT1090-Bevacizumab Biosimilar: Anti-Human VEGFA mab- Research Giredhi
2024-05-11
Kunyorwa kweprotein yeVEGF kunokonzerwa ne 'hypoxia inducible factor' munzvimbo ine hypoxia. Kana VEGF ichitenderera inosunga kune ma VEGF receptors ari pamasero e endothelial, akasiyana-siyana...
- Nhamba yekatarogu: ADT1090
- Mhando dzemhuka dzinogamuchira mhuka: Masero eCHO
- Kushandiswa: FC, IP, ELISA, Neut, FuncS, IF, ICC
- Mhando: Munhu
- Chinangwa: VEGFA [Homo sapiens]
Kubvunza
ruzivo 02
ADT1005-Abciximab Biosimilar: (ITGA2B_ITGB3)- Giredhi reKutsvagisa
2024-05-11
Abciximab, glycoprotein IIb/IIIa receptor antagonist inogadzirwa neJanssen Biologics BV uye inoparadzirwa naEli Lilly pasi pezita rekutengeserana reReoPro, inodzivirira platelet aggregation inodzivirira kunyanya...
- Nhamba yekatarogu: ADT1005
- Mhando dzemhuka dzinogamuchira mhuka: Masero eCHO
- Kushandiswa: ELISA, IHC, KANA, IP, Flow Cyt, FuncS
- Chinangwa: ITGA2B/ITGB3
Kubvunza
ruzivo 03
ADT1110-Cabiralizumab Biosimilars: Anti-CSF1R mab- Gwaro reKutsvagisa
2024-05-11
Zvinodzivirira CSF1R zvakagadzirwa senzira inogona kuderedza kuvapo kweTAMs munzvimbo ine bundu. Kubva muna 2017, zvinodzivirira CSF1R zviri kutanga...
- Nhamba yekatarogu: ADT1110
- Mhando dzemhuka dzinogamuchira mhuka: Masero eCHO
- Kushandiswa: ELISA, IHC, KANA, IP, Flow Cyt, Kudzivirira
- Chinangwa: CSF1R/CD115
Kubvunza
ruzivo 04
ADT1171-Dezamizumab Biosimilar: Anti-APCS mab- Gwaro reKutsvagisa
2024-05-11
Dezamizumab iri kuferefetwa mukuyedzwa kwekiriniki NCT03417830 (Kugoverwa kwe89Zirconium-labeled GSK2398852 Uchishandisa PET Imaging). Alpha Lifetech inodada nekupa ma antibodies akafanana neaya ...
- Nhamba yekatarogu: ADT1171
- Mhando dzemhuka dzinogamuchira mhuka: Masero eCHO
- Kushandiswa: ELISA, IHC, KANA, IP, Flow Cyt, FuncS
- Chinangwa: APCS
Kubvunza
ruzivo 05
ADT1193-Edobacomab Biosimilar: Anti-Endotoxin mab- Chidzidzo cheGiredhi
2024-05-11
Edobacomab iantibody yembeva ine monoclonal. Edobacomab, inonzi codenamed E5, iantibody yembeva ine monoclonal yakaongororwa senzira yekurapa sepsis inokonzerwa nebhakitiriya reGram-negative inokonzera chirwere ichi.
- Nhamba yekatarogu: ADT1193
- Mhando dzemhuka dzinogamuchira mhuka: Masero eCHO
- Kushandiswa: ELISA, WB
- Mhando: Gonzo
- Chinangwa: Chepfu yeEndotoxin
Kubvunza
ruzivo 
06
ADT1012-Adalimumab Biosimilar-Anti-TNF alpha mAb-Research Grade
2025-01-14
TNFR 2 iprotein yemhando yekutanga ye transmembrane glycoprotein inoita basa rakakosha mukudzora masoja emuviri. Ine amino acids angangoita 439 kusvika 461 uye ine chekuita nekuzvimba kwakasiyana-siyana...
- Nhamba yeKatarogu ADT1012
- Mugamuchiri Masero eCHO
- Chinangwa TNF alpha/TNFA/TNFSF2
- Mhando dzemhuka Munhu
- Kushandiswa FC, IP, ELISA, Neut, Kuedza kushanda
Kubvunza
ruzivo 
07
ADT1015-Aducanumab Biosimilar-Anti-APP Abeta mAb -Kutsvagisa Giredhi
2025-01-15
APP (Amyloid Beta Precursor Protein) ijini reProtein Coding. Pakati penzira dzayo dzakabatana pane Toll Like Receptor 7/8 (TLR7/8) Cascade uye GPCR downstream signalling. Alpha Lifetech inonyanya...
- Nhamba yeKatarogu ADT1015
- Mugamuchiri Masero eCHO
- Mhando dzemhuka Munhu
- Chinangwa APP/Beta
- Kushandiswa Elisa, WB
Kubvunza
ruzivo 
08
ADT1027-Amatuximab Biosimilar– Anti-MSLN mAb – Gwaro Rekutsvaga
2025-01-15
MSLN (Mesothelin) ijini rinokonzera mapuroteni. Zvirwere zvine chekuita neMSLN zvinosanganisira Benign Mesothelioma neMalignant Pleural Mesothelioma. Pakati penzira dzayo dzakabatana pane Kudzora insulin-like...
- Nhamba yeKatarogu ADT1027
- Mugamuchiri Masero eCHO
- Mhando dzemhuka Munhu
- Chinangwa MSLN/Mesothelin
- Kushandiswa Kuedza kushanda, IF, Neut, ELISA, FC, IP, ICC
Kubvunza
ruzivo 
09
ADT1043-Anti-CD28 Biosimilar Antibody– Anti-CD28(Tp44) mAb – Giredhi reKutsvagisa
2025-01-15
CD28 (CD28 Molecule) ijini reProtein Coding. Zvirwere zvine chekuita neCD28 zvinosanganisira Classic Mycosis Fungoides neSezary's Disease. Pakati penzira dzayo dzakabatana pane CD28 co-stimulation uye PI...
- Nhamba yeKatarogu ADT1043
- Mugamuchiri Masero eCHO
- Mhando dzemhuka Munhu
- Chinangwa CD28
- Kushandiswa Elisa, WB
Kubvunza
ruzivo 
10
ADT1050-Aprutumab Biosimilar– Anti-FGFR2 mAb – Gwaro Rekutsvaga
2025-01-15
Puroteni inonyorwa nejini reFGFR2 inhengo yemhuri yefibroblast growth factor receptor, ine amino acid yakachengetedzwa zvakanyanya. Puroteni inomiririra hurefu hwakazara ine ...
- Nhamba yeKatarogu ADT1050
- Mugamuchiri Masero eCHO
- Mhando dzemhuka Munhu
- Chinangwa FGFR2
- Kushandiswa Elisa, WB
Kubvunza
ruzivo 
11
ADT1054-Atezolizumab Biosimilar– Anti-CD274, B7-H1, PDL1 mAb – Gwaro Rekutsvakurudza
2025-01-15
Jini reCD274 rinochengetedza ligand ye immunosuppressive receptor inoratidzwa nemasero e hematopoietic neasiri e hematopoietic, akadai semasero eT nemasero eB, pamwe nemarudzi akasiyana-siyana emasero e bundu. Encod...
- Nhamba yeKatarogu ADT1054
- Mugamuchiri Masero eCHO
- Mhando dzemhuka Munhu
- Chinangwa CD274/B7-H1/PDL1
- Kushandiswa ELISA, IHC, KANA, IP, Flow Cytometry
Kubvunza
ruzivo 
12
ADT1061-Avelumab Biosimilar– Anti-PD-L1 mAb – Giredhi reKutsvagisa
2025-01-15
CD274, inozivikanwawo sePDL1, i ligand inosunga kune common receptor PD1 pamasero eT uye inoshandiswa kudzivirira kushanda kwemasero eT. Kuonekwa kwePD1 kwakaonekwa mukenza dzakasiyana-siyana, kusanganisira m...
- Nhamba yeKatarogu ADT1061
- Mugamuchiri Masero eCHO
- Mhando dzemhuka Munhu
- Chinangwa CD274/B7-H1/PDL1
- Kushandiswa Elisa, WB
Kubvunza
ruzivo